These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8823357)

  • 21. Autoantibodies against cell adhesion molecules in pemphigus.
    Amagai M
    J Dermatol; 1994 Nov; 21(11):833-7. PubMed ID: 7852644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production.
    Nishifuji K; Amagai M; Kuwana M; Iwasaki T; Nishikawa T
    J Invest Dermatol; 2000 Jan; 114(1):88-94. PubMed ID: 10620121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals.
    Veldman CM; Gebhard KL; Uter W; Wassmuth R; Grötzinger J; Schultz E; Hertl M
    J Immunol; 2004 Mar; 172(6):3883-92. PubMed ID: 15004196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneous MHC II restriction pattern of autoreactive desmoglein 3 specific T cell responses in pemphigus vulgaris patients and normals.
    Hertl M; Karr RW; Amagai M; Katz SI
    J Invest Dermatol; 1998 Apr; 110(4):388-92. PubMed ID: 9540980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients.
    Amagai M; Koch PJ; Nishikawa T; Stanley JR
    J Invest Dermatol; 1996 Feb; 106(2):351-5. PubMed ID: 8601740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgaris.
    Koga H; Tsuruta D; Ohyama B; Ishii N; Hamada T; Ohata C; Furumura M; Hashimoto T
    Expert Opin Ther Targets; 2013 Mar; 17(3):293-306. PubMed ID: 23294403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controversial role of antibodies against linear epitopes of desmoglein 3 in pemphigus vulgaris, as revealed by semiquantitative living cell immunofluorescence microscopy and in-cell ELISA.
    Lanza A; Perillo L; Landi C; Femiano F; Gombos F; Cirillo N
    Int J Immunopathol Pharmacol; 2010; 23(4):1047-55. PubMed ID: 21244754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris.
    Müller R; Svoboda V; Wenzel E; Müller HH; Hertl M
    Exp Dermatol; 2008 Jan; 17(1):35-43. PubMed ID: 18095943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of antibodies against the non-calcium-dependent epitopes of desmoglein 3 in pemphigus vulgaris and their pathogenic significance.
    Kamiya K; Aoyama Y; Shirafuji Y; Hamada T; Morizane S; Fujii K; Hisata K; Iwatsuki K
    Br J Dermatol; 2012 Aug; 167(2):252-61. PubMed ID: 22404487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tryptic cleavage product of the mature form of the bovine desmoglein 1 ectodomain is one of the antigen moieties immunoprecipitated by all sera from symptomatic patients affected by a new variant of endemic pemphigus.
    Abréu-Vélez AM; Javier Patiño P; Montoya F; Bollag WB
    Eur J Dermatol; 2003; 13(4):359-66. PubMed ID: 12948916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoplasmic reticulum targeting and glycosylation of hybrid proteins in transgenic tobacco.
    Iturriaga G; Jefferson RA; Bevan MW
    Plant Cell; 1989 Mar; 1(3):381-90. PubMed ID: 2535509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.
    Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevance of differential immunogenicity of human and mouse recombinant desmoglein-3 for the induction of acantholytic autoantibodies in mice.
    Kaithamana S; Fan JL; Memar O; Li K; Uitto J; Seetharamaiah GS; Prabhakar BS
    Clin Exp Immunol; 2003 Apr; 132(1):16-23. PubMed ID: 12653831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris.
    Tsunoda K; Ota T; Suzuki H; Ohyama M; Nagai T; Nishikawa T; Amagai M; Koyasu S
    Eur J Immunol; 2002 Mar; 32(3):627-33. PubMed ID: 11857336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an enzyme-linked immunosorbent assay for detection of circulating IgG autoantibodies against canine desmoglein 3 in dogs with pemphigus.
    Nishifuji K; Tamura K; Konno H; Olivry T; Amagai M; Iwasaki T
    Vet Dermatol; 2009 Oct; 20(5-6):331-7. PubMed ID: 20178469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.
    Amagai M; Komai A; Hashimoto T; Shirakata Y; Hashimoto K; Yamada T; Kitajima Y; Ohya K; Iwanami H; Nishikawa T
    Br J Dermatol; 1999 Feb; 140(2):351-7. PubMed ID: 10233237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
    Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
    J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenicity and epitope characteristics of anti-desmoglein-1 from pemphigus foliaceus patients expressing only IgG1 autoantibodies.
    Hacker-Foegen MK; Janson M; Amagai M; Fairley JA; Lin MS
    J Invest Dermatol; 2003 Dec; 121(6):1373-8. PubMed ID: 14675185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris.
    Spaeth S; Riechers R; Borradori L; Zillikens D; Büdinger L; Hertl M
    Br J Dermatol; 2001 Jun; 144(6):1183-8. PubMed ID: 11422039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.